Amiodarone Alters Cholesterol Biosynthesis through Tissue-Dependent Inhibition of Emopamil Binding Protein and Dehydrocholesterol Reductase 24.

ACS Chemical Neuroscience
Luke B AllenZeljka Korade


Amiodarone is prescribed for the treatment and prevention of irregular heartbeats. Although effective in clinical practice, the long-term use of amiodarone has many unwanted side effects, including cardiac, pulmonary, hepatic, and neurological toxicities. Our objective was to elucidate effects of amiodarone exposure on the cholesterol metabolism in cultured neuronal and non-neuronal cells and in individuals taking amiodarone. We observed that amiodarone increases distinct cholesterol precursors in different cell types in a dose-dependent manner. In liver and kidney cell lines, amiodarone causes increase in desmosterol levels, and in primary cortical neurons and astrocytes, amiodarone increases zymosterol, zymostenol, and 8-dehydrocholesterol (8-DHC). We conclude that amiodarone inhibits two enzymes in the pathway, emopamil binding protein (EBP) and dehydrocholesterol reductase 24 (DHCR24). Cortical neurons and astrocytes are more sensitive to amiodarone than liver and kidney cell lines. We confirmed the inhibition of EBP enzyme by analyzing the sterol intermediates in EBP-deficient Neuro2a cells versus amiodarone-treated control Neuro2a cells. To determine if the cell culture experiments have clinical relevance, we analyzed ser...Continue Reading


Jun 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·A G FraserM R Stephens
Sep 15, 1988·The American Journal of Cardiology·P T PollakS G Carruthers
Feb 1, 1987·Acta Ophthalmologica·G R Duff, A G Fraser
Nov 1, 1994·Journal of Cardiovascular Pharmacology·S P LubicJ C Giacomini
Feb 1, 1995·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·M N Dekleva, B B Beleslin
Nov 26, 1993·The American Journal of Cardiology·D M Roden
Mar 12, 1999·The American Journal of Cardiology·P T Pollak, M H Tan
Jun 29, 2000·Clinical Pharmacology and Therapeutics·P T PollakS L Shafer
Dec 28, 2002·American Journal of Medical Genetics. Part a·David J AughtonRichard M Pauli
Mar 5, 2003·Age and Ageing·Amitalh SinghalShahid Anis Khan
May 23, 2003·The Biochemical Journal·Fabian F MoebiusHartmut Glossmann
Nov 15, 2005·The American Journal of the Medical Sciences·Srinivas R PuliMartin A Alpert
May 27, 2008·Journal of Lipid Research·Akira HondaYasushi Matsuzaki
Aug 5, 2008·Journal of Molecular Neuroscience : MN·Zeljka KoradeBruce D Carter
Oct 28, 2008·Journal of Neuroscience Research·Zeljka KoradeKároly Mirnics
Jul 15, 2009·Archives of Neurology·Carolyn F Orr, J Eric Ahlskog
Mar 10, 2010·Sub-cellular Biochemistry·Irena LevitanVictor Romanenko
Apr 3, 2010·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zeljko MikovicGordana Dragovic Lukic
Sep 1, 2011·Biochemical Pharmacology·Elena PiccoliAldo Baritussio
Mar 6, 2012·The American Journal of Medicine·Rod S PassmanJune M McKoy
Mar 1, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marko SimonenJussi Pihlajamäki
Feb 14, 2014·Frontiers in Cellular Neuroscience·Andrea GoudriaanMark H G Verheijen
Aug 26, 2015·Journal of Biomolecular Screening·Edward S A Humphries, Caroline Dart
Sep 8, 2015·Toxicology and Applied Pharmacology·Justin D Schumacher, Grace L Guo
Mar 15, 2016·Frontiers in Pharmacology·Mohammad-Reza GhovanlooPeter C Ruben
Sep 2, 2017·Journal of Internal Medicine·P SimonenH Gylling
Oct 1, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Noam ErezOren Shibolet
Nov 28, 2017·Journal of Internal Medicine·A J Brown, I C Gelissen
Mar 21, 2019·Journal of Inherited Metabolic Disease·Luke B AllenZeljka Korade
Jun 28, 2019·ACS Chemical Neuroscience·Thiago C Genaro-MattosKároly Mirnics

❮ Previous
Next ❯


Sep 11, 2020·Human & Experimental Toxicology·Wan XuLixin Shang
Feb 3, 2021·ACS Chemical Neuroscience·Keri A TallmanZeljka Korade
Oct 15, 2020·The Journal of Biological Chemistry·Laura J SharpeAndrew J Brown
Feb 3, 2021·Translational Psychiatry·Zeljka KoradeKaroly Mirnics
Jan 18, 2021·The Journal of Biological Chemistry·Laura J SharpeAndrew J Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Related Papers

Critical Care Nurse
R DeAngelis
Der Internist
B D Gonska
S M Sobol, L Rakita
Iowa Medicine : Journal of the Iowa Medical Society
M G Kienzle
© 2022 Meta ULC. All rights reserved